The newest Global TB Report stresses that tuberculosis cannot be stopped without new tools, drugs and ways of working. Unitaid has been intensifying its TB investments to bring about these crucial innovations.

At this week’s Union Conference, Unitaid presents new projects that are developing child-friendly treatments and preventive therapy for multidrug-resistant tuberculosis, bringing in fast, accurate, gene-based diagnosis, and piloting technologies to help patients adhere to TB treatment. We are honored to play a role in #EndingTheEmergency.

We are also excited to announce a landmark agreement between Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global biopharmaceutical company Sanofi that will significantly lower the price – by nearly 70% — of rifapentine, a critically important drug used to prevent TB. The deal could stop millions from developing the life-threatening disease.

Our press releases:

• Landmark deal secures significant discount on price of medicine to prevent TB
• Unitaid introduces its newest tuberculosis-fighting projects at Union World Conference

Unitaid in the Press:

• Antibiotic price drop could stop millions from developing tuberculosis. The Guardian, 31 Oct 2019.
• Interview with BBC Newsday (go to 12min:52sec): Director of Operations, Unitaid, Robert Matiru. BBC, 1 Nov 2019.
• Sanofi inks pact with Unitaid; To reduce TB drug Rifapentine price by 70%. The Economic Times, 31 Oct 2019.
• Deal slashes preventive TB medicine price by nearly 70%. Devex, 31 Oct 2019.
• A powerful tuberculosis drug gets a deep price cut. Science, 31 Oct 2019.
• Sanofi, Unitaid partnership cuts price of tuberculosis drug. The Hindu Business Line, 31 Oct 2019.
• New deal slashes price of drug to prevent TB by almost 70% ahead of SA roll out. bhekisisa, 31 Oct 2019.
• Tuberculosis drug price slashed in global push to thwart killer disease. channelnewsasia, 31 Oct 2019.
• TB drug price slashed in global push to thwart killer disease. rappler, 31 Oct 2019.
• Major price drop for key TB drug. Health-e News, 31 Oct 2019.
• NGS kits to help in quick diagnosis of TB cases. telanganatoday, 1 Nov 2019.
• Sanofi, Unitaid, Global Fund lower TB drug pricing. biospectrumindia, 1 Nov 2019.
• Pharma firm slashes price of TB drug by 66%. mumbaimirror.indiatimes. 1 Nov 2019.
• Réduction du prix d’un antituberculeux-clé dans 100 pays. La Provence, 31 Oct 2019.
• Sanofi: bénéfice net en recul de 22,3% au 3T, objectifs confirmés. Le Soir, 31 Oct 2019.
• TB drug price slashed in global push to thwart killer disease. The East African. 31 Oct 2019.
• Tuberculosis drug price slashed in global push to thwart killer disease. Jamaica Observer. 31 Oct 2019.

Unitaid’s work in TB:

• Unitaid and tuberculosis (Factsheet)
• Unitaid TB Portfolio (Factsheet)
• Unitaid TB project pages (Our website)
• Expanding access to next generation drug-resistant tuberculosis treatment (Impact story)
• Improving use of tuberculosis diagnostics (Impact story)
• Childhood tuberculosis (Impact story)

Watch our short films and animations:

• Fighting MDR-TB in Peru (Film)
• Preventing TB in South Africa (Film)
• Better treatment for children with tuberculosis (Animation)
• Innovating to fight drug resistance (Animation)
• Peru pioneers new treatment for drug-resistant TB (Photo story)

For more information on the 50th Union World Conference on Lung Health, please visit its official website: https://hyderabad.worldlunghealth.org